Allergan Announces New Board Member: Robert A. Ingram Appointed

28-Jan-2005

Allergan, Inc. announced the appointment of Robert A. Ingram to the Company's Board of Directors.

Since January 2003, Mr. Ingram has been the Vice Chairman Pharmaceuticals of GlaxoSmithKline plc, a corporation involved in the research, development, manufacturing and sale of pharmaceuticals. Prior to that, he was Chief Operating Officer and President, Pharmaceutical Operations of GlaxoSmithKline plc (January 2001 to January 2003); Chief Executive Officer of Glaxo Wellcome plc (October 1997 to December 2000); and Chairman of Glaxo Wellcome Inc., Glaxo Wellcome plc's United States subsidiary (January 1999 to December 2000). In addition to his longstanding career at Glaxo, Mr. Ingram serves on the boards of Edwards Lifesciences Corporation, Lowe's Companies, Inc., and Wachovia Corporation. He also serves as Chairman, OSI Pharmaceuticals, Inc.

Mr. Ingram received his bachelor of science degree in business administration from Eastern Illinois University. He is involved in numerous civic and professional organizations and currently serves as Chairman of the Board of Trustees of the American Cancer Society Foundation. In January 2004, Mr. Ingram was awarded the Martin Luther King, Jr. Legacy Award for International Service.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances